Taylor Kantor
@taylorkantor
Lucky Husband, Father of two, patient advocate. Co-Founder and Chief Medical Officer, Ivim Health
“I wish someone told me this earlier.” I hear it all the time. GLP-1s are powerful, but most effective when paired with lifestyle change. The best outcomes happen when science meets daily habits. #GLP1 medicalxpress.com/news/2025-10-h…
FDA approved oral semaglutide for CV risk reduction in high-risk T2D — a practical win for prevention. Pair it with earlier access and integrated care, and we avoid more invasive care down the line. #GLP1 medpagetoday.com/cardiology/gen…
U.S. obesity rates are finally declining. Not a miracle — medicine working on the biology. Now the work is ensuring outcomes mean more than a number. #GLP1 usatoday.com/story/life/hea…
New Medscape data: GLP-1s are associated with lower heart and mortality risk in psoriatic arthritis. Metabolism, inflammation, and cardiac risk are deeply connected — preventive, integrated care is the future. #GLP1 medscape.com/viewarticle/gl…
New data: metabolic surgery still outperforms GLP-1s on long-term cost. The problem isn’t the tools — it’s how late we use them. Prevention > repair. #GLP1 #MetabolicHealth medscape.com/viewarticle/gl…
GLP-1s continue to show reduced heart attack and stroke risk. Prevention beats intervention every time. #GLP1 medpagetoday.com/primarycare/ob…
New research suggests some GLP-1s could lower heart attack risk even without major weight loss. Tackling metabolic inflammation early may be key to preventing cardiac events before they reach the OR. #CardiometabolicHealth #PreventiveCare #GLP1 theguardian.com/science/2025/o…
That’s a wrap on #HLTH2025. Big momentum around prevention, AI, and new care models — now it’s time to turn ideas into traction.
At @HLTHEVENT, #HLTHUSA 2025, the real innovation isn’t new tech, it’s rethinking care itself. Let’s build a system that keeps people healthy, not just treats them sick. Prevention is the new prescription. #HealthcareInnovation #Prevention #PatientFirst
GLP-1s don’t just help with weight loss; they protect the heart. Prevention and proactive care should be the standard, not the exception. #HeartHealth #MetabolicCare healthline.com/health-news/gl…
When outcomes are comparable, access and affordability matter more than ever. GLP-1s are helping make preventive, whole-person care a reality for more patients. #GLP1 #PreventiveCare medscape.com/viewarticle/si…
New research shows semaglutide’s impact on liver health in MASH may be measurable through noninvasive tests — a safer, smarter step toward precision metabolic care. #GLP1 #MASH #ClinicalCare #MetabolicHealth medscape.com/viewarticle/no…
GLP-1s are now first-line therapy for obesity, and their cardiovascular benefits make that well deserved. Prevention is powerful when guided by clinicians who see beyond weight to long-term health. #GLP1 #PreventiveCare #IvimHealth medscape.com/viewarticle/se…
Rising use of GLP-1s before surgery shows patients and clinicians are thinking earlier and smarter about obesity management. #GLP1 #PreventiveHealth healthday.com/health-news/we…
Early data combining a CB1 inhibitor with Wegovy show a promising step toward integrated metabolic care. The results suggest added weight loss benefit, but larger studies are needed to confirm safety and durability — because innovation only matters when paired with responsible,…
Costco sells Wegovy & Ozempic at $499/month. Price alone isn’t enough. Without oversight, side effects rise and adherence drops. At Ivím Health, specialists + coaches guide therapy safely, helping patients achieve lasting results. thehill.com/policy/healthc…
EASO backs GLP-1s as first-line obesity treatment. Earlier, smarter intervention means fewer late-stage crises. #Prevention #GLP1 reuters.com/business/healt…
Inflammation is a root of many chronic diseases. Evidence now supports GLP-1 therapies that may help moderate it. Prevention and biology together mean better care. #GLP1 #PreventiveHealth pmc.ncbi.nlm.nih.gov/articles/PMC10…
Weight-loss drugs may help reduce cancer risk in women, a new study shows. The right treatments don’t just solve one problem, they shape future health. #GLP1 #FutureOfCare #CancerPrevention foxnews.com/health/weight-…
Diabetes. Weight. Alzheimer’s. Research suggests GLP-1s may play a role across all three. It’s a reminder: today’s care decisions shape tomorrow’s health. #GLP1 #FutureOfCare #Alzheimers #Healthcare medscape.com/viewarticle/so…
United States الاتجاهات
- 1. New York 25.6K posts
- 2. New York 25.6K posts
- 3. Virginia 543K posts
- 4. Prop 50 190K posts
- 5. Texas 231K posts
- 6. #DWTS 41.5K posts
- 7. Clippers 9,784 posts
- 8. Van Jones 2,686 posts
- 9. TURN THE VOLUME UP 24.3K posts
- 10. Harden 10.1K posts
- 11. Ty Lue 1,012 posts
- 12. Jay Jones 105K posts
- 13. #XLOV 10.2K posts
- 14. #RadioStatic 4,067 posts
- 15. #QuestPit 6,621 posts
- 16. WOKE IS BACK 40.9K posts
- 17. #Election2025 16.8K posts
- 18. Bulls 37.6K posts
- 19. Eugene Debs 3,420 posts
- 20. AND SO IT BEGINS 9,316 posts
Something went wrong.
Something went wrong.